Revenue and profits grew year-over-year, driven by robust demand for medical information systems and strong order intake. Cash position and equity ratio improved, with further growth and higher dividends forecast for FY2025.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.